THE BUSINESS OF BIOTECH VIDEOCAST

54:07 BoB_1280x720_Ebrahim_Delpassand
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

On this week's Business of Biotech episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix talks about his personal journey standing up and growing a radiopharmaceutical company focused on oncology.

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Roger Cone
Courage Therapeutics
PLAY
Amber Salzman
Epicrispr Biotechnologies
PLAY
Jennifer Hawks Bland
NewYorkBIO
PLAY
Barry Quart
Connect Biopharma
PLAY
Thomas Levenson
PLAY
Srinivas Rao
atai Life Sciences
PLAY
Yaniv Sneor
Native State Therapeutics
PLAY
Apple Spotify   YouTube

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

LINKEDIN

Interested in joining us on air? Contact us

INFO ABOUT AN UPCOMING EVENT OR PROMOTION CAN GO HERE. CLICK HERE FOR MORE INFO.

RECENT EPISODES

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

45:41 BoB_1280x720_Ep263

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

54:23 24_01_BoB_1280x720_Ep262

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

More Podcasts

FINANCE & CAPITAL MARKETS

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

33:39 24_01_BoB_1280x720_Ep137

BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez

51:00 24_01_BoB_1280x720_Ep108

Fed Funding: Creative Capital Generation With James Thomas Coates, Ph.D.

1:04:44 24_01_BoB_1280x720_Ep213

The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.

36:35 24_01_BoB_1280x720_Ep52

Biopharma PR 101 With Matt Middleman, M.D.

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

48:32 24_01_BoB_1280x720_Ep62

Creating Competitive Differentiation With Allan Shaw

51:07 24_01_BoB_1280x720_Ep189

Managing Mergers With Sail's Guillaume Pfefer, Ph.D

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

46:39 24_01_BoB_1280x720_Ep26

A Look Behind, A Look Ahead With Allan Shaw

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

54:10 24_01_BoB_1280x720_Ep119

Anatomy Of A VC Deal With 4BIO's Dima Kuzmin & Ray Therapeutics' Paul Bresge

44:41 24_01_BoB_1280x720_Ep63

From Bayer To Startup Bio With AltruBio's Dr. Judy Chou

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

51:53 24_01_BoB_1280x720_Ep165

Fiscal Turnarounds With Protalix's Eyal Rubin

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

57:48 24_01_BoB_1280x720_Ep174

The Legend Steve Gorlin's Golden Rules

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

42:37 24_01_BoB_1280x720_Ep37

A CFO's Prescription For Biopharma Success

35:59 24_01_BoB_1280x720_Ep5

Episode 5: Finding Funding In Volatile Times With Ben Zeskind

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

1:14:40 24_01_BoB_1280x720_Ep155

Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. And Parag Shah

42:19 24_01_BoB_1280x720_Ep150

Resilient Biopharma Leadership With Ambrx's Dan O'Connor

40:16 24_01_BoB_1280x720_Ep195

Funding Alzheimer's Tx Dev with ADDF's Karen Harris

46:25 24_01_BoB_1280x720_Ep94

Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

47:52 24_01_BoB_1280x720_Ep193

Strategic Deals With CinRx's Gavin Samuels, M.D.

47:34 24_01_BoB_1280x720_Ep81

Biotech Capital Markets Forecast With Allan Shaw

49:48 24_01_BoB_1280x720_Ep111

Biotech M&A Anomalies With Allan Shaw

53:44 24_01_BoB_1280x720_Ep128

Financing Biopharma Innovation With Allan Shaw

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

37:47 24_01_BoB_1280x720_Ep152

The Innovation Reduction Act With Allan Shaw

51:02 24_01_BoB_1280x720_Ep186

Biotech Is Back With Allan Shaw

39:52 24_01_BoB_1280x720_Ep14

Dr. Randall Schatzman & The New Fundraising Norm

1:01:57 24_01_BoB_1280x720_Ep170

Veteran Advice From The C-Suite With Citius' Leonard Mazur

54:08 24_01_BoB_1280x720_Ep176

Backpacks And Biotech With Luke Timmerman

48:47 24_01_BoB_1280x720_Ep159

Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard

45:24 24_01_BoB_1280x720_Ep77

The Year's Top Stories With Allan Shaw

49:30 24_01_BoB_1280x720_Ep149

Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman

56:18 24_01_BoB_1280x720_Ep143

Approvals & Mergers: Inside Enzyvant With Bill Symonds, Pharm.D.

31:32 24_01_BoB_1280x720_Ep192

Serial Success With Triumvira's Rob Williamson

1:02:44 24_01_BoB_1280x720_Ep177

Biotech Dealmaking with Regeneron's Nouhad Husseini

1:03:40 24_01_BoB_1280x720_Ep179

Public Sector Forged, Private Sector Tested With Renovaro BioSciences' Mark Dybul, M.D.

54:03 24_01_BoB_1280x720_Ep219

Picking Biotech Jockeys With SR One's Simeon George, M.D.

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

47:22 24_01_BoB_1280x720_Ep156

Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD

59:45 24_01_BoB_1280x720_Ep147

Building Flagship Pioneering With Avak Kahvejian, Ph.D.

39:19 24_01_BoB_1280x720_Ep2

Episode 2: The Business Of Biotech: Allan Shaw

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

35:25 24_01_BoB_1280x720_Ep8

Athersys' Ivor Macleod On Bringing Big-League Financial Experience To An Emerging Biotech

34:06 24_01_BoB_1280x720_Ep22

Foundations Of Biopharma Finance With Smital Shah, MBA

40:44 24_01_BoB_1280x720_Ep89

Biotech M&A Trends With Allan Shaw

50:43 24_01_BoB_1280x720_Ep191_2

The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.

46:21 24_01_BoB_1280x720_Ep80

Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

55:03 24_01_BoB_1280x720_Ep184

Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

56:10 24_01_BoB_1280x720_Ep141

Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.

40:13 24_01_BoB_1280x720_Ep201

A New Prescription For PBMs with Allan Shaw

1:03:34 24_01_BoB_1280x720_Ep173

CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt

47:38 24_01_BoB_1280x720_Ep161

Biotech Cash Management With Allan Shaw

46:25 24_01_BoB_1280x720_Ep100

The Biotech Beatdown With Allan Shaw

1:00:43 24_01_BoB_1280x720_Ep172

Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.

49:47 24_01_BoB_1280x720_Ep183

Art Of The Pivot With Elevation Oncology's Joe Ferra

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

44:34 24_01_BoB_1280x720_Ep4

Episode 4: Building Your Pitch With Leslie Williams

35:37 24_01_BoB_1280x720_Ep3

Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

30:38 24_01_BoB_1280x720_Ep55

Talking SPAC With Allan Shaw

38:29 24_01_BoB_1280x720_Ep20

CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

1:08:42 24_01_BoB_1280x720_Ep180

IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel

48:30 24_01_BoB_1280x720_Ep60

iNK T-Cell Immuno-oncology For Solid Tumors With Dr. Ian Walters

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

More From Finance & Capital Markets

DISCOVERY/R&D

35:46 24_01_BoB_1280x720_Ep10

Building A Biotech Around Your Therapeutic Platform

34:15 24_01_BoB_1280x720_Ep13

Myeloid Cells, Transplants, & Immuno-Oncology Inspiration

42:23 24_01_BoB_1280x720_Ep23

Bacterial Therapy: Modulation Of The Microbiome

1:00:41 24_01_BoB_1280x720_Ep146

Therapeutic Molecules From Moss with eleva's Andreas Schaaf And Björn Cochlovius, Ph.D.

49:40 24_01_BoB_1280x720_Ep86

AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

59:02 24_01_BoB_1280x720_Ep106

Changing The Diabetes Care Paradigm With Arecor's Dr. Sarah Howell

50:03 24_01_BoB_1280x720_Ep88

Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

33:43 24_01_BoB_1280x720_Ep7

Leaving The Incubator With Kavitha Iyer Rodrigues

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

More From Discovery/R&D

REGULATORY

41:26 BoB_Ep11

Taking ADCs Across The Finish Line

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

36:19 BoB_Ep35_2

Preparing For The Clinic With Amolyt Pharma's Dr. Thierry Abribat

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

39:26 24_01_BoB_1280x720_Ep16

Data Quality & Master Files With Dr. Robert Hariri

37:03 BoB_Ep67_2

The Clinical Trials Conundrum With Allan Shaw

41:57 BoB_Ep85_2

Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

More From Regulatory